• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    5.86 Down 0.46(7.28%) Feb 8, 4:00PM EST
    Prev Close:6.32
    Open:6.21
    Bid:4.95 x 400
    Ask:11.00 x 300
    1y Target Est:10.07
    Beta:2.11241
    Earnings Date:Mar 3 - Mar 7 (Est.)
    Day's Range:5.67 - 6.35
    52wk Range:5.67 - 12.94
    Volume:2,094,783
    Avg Vol (3m):2,096,000
    Market Cap:800.15M
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACHNDown 7.28%800.15M
    GSKDown 3.16%95.52B
    JNJUp 1.45%282.23B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):24.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.12
    Quarterly EPS Est (Dec-15) :0.07
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-3.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback